-
Proposal for necessary amendments of Annex I (NGT 1 plants)
TESTBIOTECH Background 19 – 11 – 2025 Summary The current compromise text to define criteria for Category 1 NGT status (Annex I) is based on a general misconception and is not in accordance with current scientific evidence. In short, the proposal does not consider that recombinant enzymatic mutagens, such as CRISPR/Cas, give rise to biological…
-
Input to ‘Call For Evidence for the Initiative Food and feed safety – simplification omnibus’
TESTBIOTECH Background 14 – 10 – 2025
-
Testbiotech comment on assessment of genetically modified soybean DBN9004 (application EFSA-GMO-BE-2019-165) by Beijing DaBeiNong Biotechnology
Soybean DBN9004 contains genes conferring resistance to two groups of herbicides: In its opinion, EFSA comes to the conclusion that “soybean DBN9004 is as safe as the conventional counterpart and non-GM soybean varieties tested” (EFSA, 2025a).